Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Jack Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Astera Labs Trading Down 3.2%
NASDAQ:ALAB opened at $330.86 on Thursday. The stock has a market cap of $56.71 billion, a P/E ratio of 223.55, a PEG ratio of 4.52 and a beta of 3.95. The stock has a 50 day simple moving average of $226.80 and a 200 day simple moving average of $176.02. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $372.37.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the company earned $0.33 EPS. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on ALAB
Hedge Funds Weigh In On Astera Labs
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Glenmede Trust Co. NA grew its stake in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the last quarter. Verus Capital Partners LLC boosted its holdings in shares of Astera Labs by 16.4% during the 1st quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after acquiring an additional 541 shares in the last quarter. Liontrust Investment Partners LLP grew its position in Astera Labs by 98.7% during the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after acquiring an additional 52,284 shares during the last quarter. SOA Wealth Advisors LLC. bought a new stake in Astera Labs during the 1st quarter worth $49,000. Finally, E20 Capital Ltd bought a new stake in Astera Labs during the 1st quarter worth $33,310,000. Institutional investors own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
